Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
155.7 USD | -2.12% | -5.06% | +25.49% |
Financials (USD)
Sales 2024 * | 260M | Sales 2025 * | 423M | Capitalization | 4.44B |
---|---|---|---|---|---|
Net income 2024 * | 46M | Net income 2025 * | 146M | EV / Sales 2024 * | 14.9 x |
Net cash position 2024 * | 564M | Net cash position 2025 * | 739M | EV / Sales 2025 * | 8.74 x |
P/E ratio 2024 * |
82
x | P/E ratio 2025 * |
30.4
x | Employees | 229 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.22% |
Latest transcript on Krystal Biotech, Inc.
1 day | -2.12% | ||
1 week | -5.06% | ||
Current month | -12.50% | ||
1 month | -8.13% | ||
3 months | +28.99% | ||
6 months | +35.48% | ||
Current year | +25.49% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 59 | 16-04-14 | |
Suma M. Krishnan
FOU | Founder | 59 | 16-04-14 |
Ram Kamineni
CTO | Chief Tech/Sci/R&D Officer | - | 22-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Janney
BRD | Director/Board Member | 58 | 16-10-31 |
Suma M. Krishnan
FOU | Founder | 59 | 16-04-14 |
Dino Rossi
BRD | Director/Board Member | 69 | 17-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.16% | 0 M€ | 0.00% | - | |
0.14% | 0 M€ | 0.00% | - | |
0.06% | 773 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 155.7 | -2.12% | 242,424 |
24-04-24 | 159 | -1.85% | 237,974 |
24-04-23 | 162 | +3.05% | 223,172 |
24-04-22 | 157.2 | -0.81% | 341,813 |
24-04-19 | 158.5 | -3.32% | 341,399 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.49% | 4.44B | |
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.79% | 22.02B | |
-17.84% | 20.9B | |
-11.11% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |
- Stock Market
- Equities
- KRYS Stock